Sharescart Research Club logo ×
Screener Research Unlisted Startup Funding New IPO New

Sonalis Cons Product

₹68.3 3.3 | 5%

Market Cap ₹14 Cr.

Stock P/E 2403.2

P/B 2.4

Current Price ₹68.3

Book Value ₹ 28.2

Face Value 10

52W High ₹92.3

Dividend Yield 0%

52W Low ₹ 0

Sonalis Cons Product Research see more...

Overview Inc. Year: 2022Industry: Consumer Food

Sonalis Cons Product Share Price

New

| |

Volume
Price

Quarterly Price

Show Value Show %

Sonalis Cons Product Quarterly Results

#(Fig in Cr.) Mar 2023
Net Sales 7
Other Income 0
Total Income 7
Total Expenditure 6
Operating Profit 0
Interest 0
Depreciation 0
Exceptional Income / Expenses 0
Profit Before Tax 0
Provision for Tax 0
Profit After Tax 0
Adjustments 0
Profit After Adjustments 0
Adjusted Earnings Per Share 0

Sonalis Cons Product Profit & Loss

#(Fig in Cr.) Mar 2022 Mar 2023 TTM
Net Sales 0 7 7
Other Income 0 0 0
Total Income 0 7 7
Total Expenditure 0 6 6
Operating Profit 0 0 0
Interest 0 0 0
Depreciation 0 0 0
Exceptional Income / Expenses 0 0 0
Profit Before Tax 0 0 0
Provision for Tax 0 0 0
Profit After Tax 0 0 0
Adjustments 0 0 0
Profit After Adjustments 0 0 0
Adjusted Earnings Per Share 0 0 0

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 0% 0% 0% 0%
Operating Profit CAGR 0% 0% 0% 0%
PAT CAGR 0% 0% 0% 0%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR NA% NA% NA% NA%
ROE Average 0% 0% 0% 0%
ROCE Average 1% 1% 1% 1%

Sonalis Cons Product Balance Sheet

#(Fig in Cr.) Mar 2022 Mar 2023
Shareholder's Funds 0 3
Minority's Interest 0 0
Borrowings 0 2
Other Non-Current Liabilities 0 0
Total Current Liabilities 0 1
Total Liabilities 0 6
Fixed Assets 0 0
Other Non-Current Assets 0 0
Total Current Assets 0 6
Total Assets 0 6

Sonalis Cons Product Cash Flow

#(Fig in Cr.) Mar 2022 Mar 2023
Opening Cash & Cash Equivalents 0 0
Cash Flow from Operating Activities 0 -4
Cash Flow from Investing Activities 0 -0
Cash Flow from Financing Activities 0 5
Net Cash Inflow / Outflow 0 1
Closing Cash & Cash Equivalent 0 1

Sonalis Cons Product Ratios

# Mar 2022 Mar 2023
Earnings Per Share (Rs) 0 0.03
CEPS(Rs) 0 1.05
DPS(Rs) 0 0
Book NAV/Share(Rs) 10 26.64
Core EBITDA Margin(%) 0 2.23
EBIT Margin(%) 0 0.59
Pre Tax Margin(%) 0 0.44
PAT Margin (%) 0 0.05
Cash Profit Margin (%) 0 1.7
ROA(%) 0 0.1
ROE(%) 0 0.21
ROCE(%) 0 1.49
Receivable days 0 48.22
Inventory Days 0 167.75
Payable days 0 28.55
PER(x) 0 0
Price/Book(x) 0 0
Dividend Yield(%) 0 0
EV/Net Sales(x) 0 0.31
EV/Core EBITDA(x) 0 13.72
Net Sales Growth(%) 0 0
EBIT Growth(%) 0 0
PAT Growth(%) 0 0
EPS Growth(%) 0 0
Debt/Equity(x) 0 0.81
Current Ratio(x) 0 5.44
Quick Ratio(x) 0 2.79
Interest Cover(x) 0 4.07
Total Debt/Mcap(x) 0 0

Sonalis Cons Product Shareholding Pattern

# Jun 2023 Sep 2023 Dec 2023 Mar 2024
Promoter 38.59 38.59 38.59 38.59
FII 0 0 0 0
DII 0 0 0 0
Public 61.41 61.41 61.41 61.41
Others 0 0 0 0
Total 100 100 100 100

Pros

Cons

  • Promoter holding is low: 38.59%.
  • Company has a low return on equity of 0% over the last 3 years.
  • Debtor days have increased from 0 to 28.55days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Sonalis Cons Product News

Top Unlisted Companies & InstaBuy Companies

Sell or Purchase Share (Tentative Price)

IPO

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....